The global obesity therapeutics market, valued at US$3.92 billion in 2024, is projected to reach US$20.84 billion by 2033 at a 20.6% CAGR. Explore drivers like GLP-1 receptor agonists' surge, oral treatment expansions, and chronic disease status amid projections of US$130 billion in weight-loss pharmaceuticals by 2030. https://finance.yahoo.com/news/competitive-landscape-obesity-therapeutics-market-141800112.html